Kidney and urologic disease status update: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(104 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
{{Organ System Project}}
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]'''
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]'''
==Status Updates==
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
|-
|Completed
|15
|-
|In progress
|6
|-
|Remaining
|3
|-
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
|-
|Completed
|12
|-
|In progress
|6
|-
|Remaining
|5
|}
==Primary Care Topics==
{| class="wikitable sortable"
! colspan="4" |Primary care chapters
! colspan="3" |Primary care resident survival guides
|-
!Specialty
!Topic
!Author
!Status
!Resident Survival Guide Page
!Author
!Status
|-
|Nephrology||[[Acute kidney injury]]
|Farima kahe
|Complete
|[[Acute kidney failure resident survival guide]]||Kanwal Khmuani||Needs some review
|-
|Nephrology||[[Acidosis]]
|Carlos
|Needs review
|[[Acidosis resident survival guide]]|| ||P
|-
|Nephrology||[[Alkalosis]]
|Mydah
|In progress
|[[Alkalosis resident survival guide]]|| ||Needs content
|-
|Nephrology||[[Hyperkalemia]]
|Jogeeth Singh
|Complete
|[[Hyperkalemia resident survival guide]]||Mahmoud||Complete
|-
|Nephrology||[[Hypokalemia]]
|Cafer Zorkun
|Needs some content
|[[Hypokalemia resident survival guide]]|| ||Complete
|-
|Nephrology||[[Hypernatremia]]
|Feham Tariq
|Complete
|[[Hypernatremia resident survival guide]]||Mounika (Ahmed's scholar)||Being reviewed
|-
|Nephrology||[[Hyponatremia]]
|
|Needs content
|[[Hyponatremia resident survival guide]]||Priyamvada||Complete
|-
|Nephrology||[[Metabolic acidosis]]
|Sidra Kalsoom
|Needs review
|[[Metabolic acidosis resident survival guide]]||Ogheneochuko||Complete
|-
|Nephrology||[[Metabolic alkalosis]]
|Marufa Marium
|Needs review
|[[Metabolic alkalosis resident survival guide]]||Marufa Marium||Needs English Review
|-
|Nephrology||[[Respiratory acidosis]]
|Nasrin
|Assigned needs content
|[[Respiratory acidosis resident survival guide]]||Qasim Khurshid||Needs English Review
|-
|Nephrology||[[Respiratory alkalosis]]
|
|Complete
|[[Respiratory alkalosis resident survival guide]]||Rinky Agnes
|Needs review
|-
|Nephrology||[[Nephrolithiasis]]
|Amandeep Singh
|Complete
|[[Nephrolithiasis resident survival guide]]|| ||Complete
|-
|Nephrology
|[[Nocturia]]
|Sivakrishna Kumar, Nasrin
|Needs Review
|[[Nocturia resident survival guide]]
|Sidra
|In progress
|-
|Nephrology||[[Polyuria]]
|Amandeep Singh
|Complete
|[[Polyuria resident survival guide]]||Zaida
|In progress
|-
|Nephrology||[[Renal artery stenosis]]
|Shivam Singla
|Assigned
|[[Renal artery stenosis resident survival guide]]||Karol||Complete
|-
|Nephrology
|[[Hematuria]]
|Sivakrishna Kumar
|Needs review
|[[Hematuria resident survival guide]]
|Tayyaba Ali
|Needs English review
|-
|Nephrology
|[[Dysuria]]
|Nabeel
|In progress
|[[Dysuria resident survival guide]]
|Rinky
|Complete
|-
|Nephrology
|[[Flank pain]]
|Samantha Salomun
|In progress
|[[Flank pain resident survival guide]]
|Qasim Khurshid
|Needs English review
|-
|Nephrology
|[[Urinary tract infection]]
|Usama Talib
|Complete
|[[Urinary tract infection resident survival guide]]
|
|Complete
|-
|Nephrology
|[[Pyuria]]
|Sadaf
|Complete
|[[Pyuria resident survival guide]]
|Ibtisam Ashraf
|Needs English Review
|-
|Nephrology
|[[Hypertension]]
|Usama Talib
|Complete
|[[Hypertension resident survival guide]]
|
|Complete
|-
|Nephrology
|[[Edema generalized|Edema]]
|Mydah
|Complete
|[[Edema resident survival guide]]
|Sara zand
|In progress
|-
|Nephrology
|[[Urinary retention]]
|Luke Orazem
|Assigned(Sidra Kalsoom)
|[[Urinary retention resident survival guide]]
|Kanwal Khmuani
|Needs English review
|-
|Nephrology
|[[Urinary incontinence]]
|Maneesha
|In progress
|[[Urinary incontinence resident survival guide]]
|Maneesha
|Complete
|-
|}


{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"class="wikitable"
==Status Update==
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
|+
! colspan="2" style="background:#efefef;" |Progress
! colspan="2" style="background:#efefef;" |Progress
|-
|-
|Completed
|Completed
|33
|35
|-
|-
|In progress  
|In progress
|1
|4
|-
|-
|Remaining  
|Remaining
|30
|37
|}
|}
== List of Chapters Requiring Content ==
==List of Chapters Requiring Content==


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Assignment Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Scholar's name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Coach name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Completion Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Review status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}}
|-
|-
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
Line 38: Line 234:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Acute uric acid nephropathy  
*Acute uric acid nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 47: Line 243:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Albuminuria
*Albuminuria
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 56: Line 252:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Analgesic nephropathy
*Balkan nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey, Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Balkan nephropathy  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 74: Line 261:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Bartter syndrome
*Bartter syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 83: Line 270:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Beer potomania
*Beer potomania
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 92: Line 279:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Boyd-Stearns syndrome
*Boyd-Stearns syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 101: Line 288:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Branchio-oto-renal syndrome
*[[Branchio-oto-renal syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 110: Line 297:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Continuous veno-venous hemofiltration
*Continuous veno-venous hemofiltration
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 119: Line 306:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Calix diverticulum
*Calix diverticulum
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 128: Line 315:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Contrast-induced acute kidney injury
*Contrast-induced acute kidney injury
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 137: Line 324:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Cholesterol emboli syndrome
*Cholesterol emboli syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Abdul
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 146: Line 333:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Crush syndrome
*Crush syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Akash Hans
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 155: Line 342:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* C4 glomerulopathy
*C4 glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |{{ADG}}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 164: Line 351:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Dent's disease
*Dent's disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 173: Line 360:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Dialysis (LP)
*Dialysis (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 182: Line 369:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Diuresis
*Diuresis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 191: Line 378:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Fibrillary immunotactoid glomerulopathy
*Fibrillary immunotactoid glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 209: Line 396:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Hypophosphatemia  
*Hypophosphatemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 218: Line 405:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Haff disease
*Haff disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Swathi Joshi
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 227: Line 414:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Hemodialysis (SP)
*Hemodialysis (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 236: Line 423:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* HIV associated nephropathy
*Hypertensive nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Hypertensive nephropathy  
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
Line 254: Line 432:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Kidney transplantation
*Kidney transplantation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 263: Line 441:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Milk-alkali syndrome
*Multicystic dysplastic kidney
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Multicystic dysplastic kidney
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 283: Line 451:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Nephroptosis
*Nephroptosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 293: Line 461:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Nutcracker syndrome
*Nutcracker syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 303: Line 471:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Papillorenal syndrome
*[[Papillorenal syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 312: Line 480:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Peritoneal dialysis (SP)
*Peritoneal dialysis (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 321: Line 489:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Phosphate nephropathy
*Phosphate nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ
Line 330: Line 498:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Pyonephrosis
*Pyonephrosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Harshwardan Chawla
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 339: Line 507:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Rhabdomyolysis  
*Rhabdomyolysis
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ,  
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ,
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 348: Line 516:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Rebound diuresis
*Rebound diuresis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 358: Line 526:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Renal agenesis
*Renal agenesis
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Renal artery stenosis
*Renal artery stenosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 375: Line 543:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Renal papillary necrosis
*Renal papillary necrosis


| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 385: Line 553:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Thin basement membrane disease
*Thin basement membrane disease


| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Marufa Marium
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 418: Line 586:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Analgesic nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |HIV associated nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Milk-alkali syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Bartter syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
Line 732: Line 900:
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian  
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
|-
|-
|-
Line 815: Line 983:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |C3 glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Vindhya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
Line 831: Line 999:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis  
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra

Latest revision as of 17:45, 25 May 2021

Organ System Project
Topics
Leaders & Members
Meetings' Summary

System leader: Maneesha Nandimandalam, MD

Status Updates

Resident survival guide Progress
Completed 15
In progress 6
Remaining 3
Primary care chapter Progress
Completed 12
In progress 6
Remaining 5

Primary Care Topics

Primary care chapters Primary care resident survival guides
Specialty Topic Author Status Resident Survival Guide Page Author Status
Nephrology Acute kidney injury Farima kahe Complete Acute kidney failure resident survival guide Kanwal Khmuani Needs some review
Nephrology Acidosis Carlos Needs review Acidosis resident survival guide P
Nephrology Alkalosis Mydah In progress Alkalosis resident survival guide Needs content
Nephrology Hyperkalemia Jogeeth Singh Complete Hyperkalemia resident survival guide Mahmoud Complete
Nephrology Hypokalemia Cafer Zorkun Needs some content Hypokalemia resident survival guide Complete
Nephrology Hypernatremia Feham Tariq Complete Hypernatremia resident survival guide Mounika (Ahmed's scholar) Being reviewed
Nephrology Hyponatremia Needs content Hyponatremia resident survival guide Priyamvada Complete
Nephrology Metabolic acidosis Sidra Kalsoom Needs review Metabolic acidosis resident survival guide Ogheneochuko Complete
Nephrology Metabolic alkalosis Marufa Marium Needs review Metabolic alkalosis resident survival guide Marufa Marium Needs English Review
Nephrology Respiratory acidosis Nasrin Assigned needs content Respiratory acidosis resident survival guide Qasim Khurshid Needs English Review
Nephrology Respiratory alkalosis Complete Respiratory alkalosis resident survival guide Rinky Agnes Needs review
Nephrology Nephrolithiasis Amandeep Singh Complete Nephrolithiasis resident survival guide Complete
Nephrology Nocturia Sivakrishna Kumar, Nasrin Needs Review Nocturia resident survival guide Sidra In progress
Nephrology Polyuria Amandeep Singh Complete Polyuria resident survival guide Zaida In progress
Nephrology Renal artery stenosis Shivam Singla Assigned Renal artery stenosis resident survival guide Karol Complete
Nephrology Hematuria Sivakrishna Kumar Needs review Hematuria resident survival guide Tayyaba Ali Needs English review
Nephrology Dysuria Nabeel In progress Dysuria resident survival guide Rinky Complete
Nephrology Flank pain Samantha Salomun In progress Flank pain resident survival guide Qasim Khurshid Needs English review
Nephrology Urinary tract infection Usama Talib Complete Urinary tract infection resident survival guide Complete
Nephrology Pyuria Sadaf Complete Pyuria resident survival guide Ibtisam Ashraf Needs English Review
Nephrology Hypertension Usama Talib Complete Hypertension resident survival guide Complete
Nephrology Edema Mydah Complete Edema resident survival guide Sara zand In progress
Nephrology Urinary retention Luke Orazem Assigned(Sidra Kalsoom) Urinary retention resident survival guide Kanwal Khmuani Needs English review
Nephrology Urinary incontinence Maneesha In progress Urinary incontinence resident survival guide Maneesha Complete

Status Update

Progress
Completed 35
In progress 4
Remaining 37

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases
  • Abderhalden-Kaufmann-Lignac syndrome
  • Acute uric acid nephropathy
  • Albuminuria
  • Balkan nephropathy
  • Bartter syndrome
Assigned Tayyaba Ali Huda
  • Beer potomania
  • Boyd-Stearns syndrome
Assigned Shivam Singla Sara Mohsin
  • Continuous veno-venous hemofiltration
  • Calix diverticulum
  • Contrast-induced acute kidney injury
  • Cholesterol emboli syndrome
Assigned Abdul Ahmed Elsaiey
  • Crush syndrome
Assigned Akash Hans Ahmed
  • C4 glomerulopathy
Assigned Norina Usman, M.B.B.S[1] Aditya Ganti M.B.B.S. [2]
  • Dent's disease
  • Dialysis (LP)
  • Diuresis
  • Fibrillary immunotactoid glomerulopathy
  • Glomerulosclerosis
  • Hypophosphatemia
  • Haff disease
Assigned Swathi Joshi
  • Hemodialysis (SP)
  • Hypertensive nephropathy
Assigned Nasrin Elsaiey,Ahmed
  • Kidney transplantation
  • Multicystic dysplastic kidney
  • Nephroptosis
  • Nutcracker syndrome
Assigned Shivam Singla Sara Mohsin
  • Peritoneal dialysis (SP)
  • Phosphate nephropathy
Assingned Ayesha FJ Sogand
  • Pyonephrosis
Assigned Harshwardan Chawla Aditya
  • Rhabdomyolysis
Assingned Ayesha FJ, Sogand
  • Rebound diuresis
  • Renal agenesis
Assigned Shakiba Elsaiey,Ahmed
  • Renal artery stenosis
  • Renal papillary necrosis
Assigned Nasrin Elsaiey,Ahmed
  • Thin basement membrane disease
Assigned Marufa Marium Maneesha

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Cardiorenal syndrome Assigned Dina Huda
Analgesic nephropathy Assigned Shakiba Elsaiey,Ahmed Yes Not done
HIV associated nephropathy Assigned Shakiba Elsaiey,Ahmed Yes Not done
Milk-alkali syndrome Assigned Shakiba Elsaiey,Ahmed Yes Not done
Bartter syndrome Assigned Tayyaba Huda Yes Not done

Completed chapters

Category Chapters Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Electrolyte imbalance (LP) Mehdi Yes Done Mehrian
Hyponatremia Saeedeh Yes Done Mahshid
Hypernatremia Feham Yes Done Elsaiey
Hypokalemia Rc-Aida Yes Done Mahshid
Hyperkalemia Jogeet Yes Done Amandeep
Hypocalcemia Krishna Yes Done Hasan
Hypercalcemia Anmol Yes Done Sudarshana Datta
Glomerular Disease(LP) Mehrian Yes Done Farima
Lupus Nephritis Aida/ Omer Yes Done Iqra
Rapidly progressive glomerulonephritis Nazia / Jogeet Yes Done Aditya
Membranous glomerulonephritis Sunny/ Seyd Yes Done Amandeep
Membranoproliferative glomerulonephritis rc Arash Yes Done Aditya
IgA nephropathy Dildar Yes Done Mehrian
Goodpasture syndrome Akshun Yes Done Farima
Amyloidosis (LP) Shamila Yes Done Mehrian
Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type(senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
C3 glomerulopathy Vindhya Yes Done
Bladder cancer Farima Kahe Yes Done
Hydronephrosis Chandra Yes Done Aditya
Kidney stone Amandeep Yes Done Aditya
Polycystic kidney disease Khurram Yes Done Anmol
Nephritic syndrome Dildar Yes Done Mehrian
Nephrotic syndrome Mehrian Yes Done Sadaf
Post-streptococcal glomerulonephritis Manpreet Yes Done Mehrian
Renal cell carcinoma Farima Yes Done Anmol
Renal osteodystrophy
Renal tubular acidosis Aditya Yes Done Sargun
Renal vein thrombosis Saeedeh Yes Done Mehdi
Wilms' tumor Sargun Yes Done Farima